glp-1 insurance coverage of Obesity Therapies in State-Regulated Markets Ro launches GLP-1 insurance coverage
Description
Insurance Coverage for GLP-1s Is Expanding Private insurers increasingly cover FDA-approved weight-loss medications (Wegovy, Saxenda) under anti-obesity drug benefits
By tailoring the user experience to their specific profiles, it is possible to improve adherence, support better outcomes and position these devices as tools for health empowerment
That is the difference between staying on protocol and quitting in week two
The problem, however, was that the molecules half-life was much too short to serve as a useful medicine
